Ipsen announces the appointment of Christelle Huguet as executive vice president, head of research and development (R&D), succeeding Howard Mayer who will leave the group on September 22 to retire.

Christelle Huguet will be part of the executive leadership team and report to CEO David Loew. She joined Ipsen in May 2020 as senior vice president, head of research, external innovation and early development (REED).

The laboratory emphasizes that it has set up a flexible and dynamic REED organization worldwide, structured around Ipsen's three therapeutic areas of oncology, rare diseases and neuroscience.

Copyright (c) 2023 CercleFinance.com. All rights reserved.